112 related articles for article (PubMed ID: 31066593)
1.
Akagi Y; Tachibana T; Orita Y; Gion Y; Marunaka H; Makino T; Miki K; Akisada N; Yoshino T; Nishizaki K; Sato Y
Acta Otolaryngol; 2019 Jul; 139(7):647-651. PubMed ID: 31066593
[No Abstract] [Full Text] [Related]
2. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
3. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue.
Harris SL; Thorne LB; Seaman WT; Hayes DN; Couch ME; Kimple RJ
Head Neck; 2011 Nov; 33(11):1622-7. PubMed ID: 21990227
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
[TBL] [Abstract][Full Text] [Related]
5. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy.
Gilbert DC; Williams A; Allan K; Stokoe J; Jackson T; Linsdall S; Bailey CM; Summers J
Radiother Oncol; 2013 Oct; 109(1):146-51. PubMed ID: 24021343
[TBL] [Abstract][Full Text] [Related]
6. Young adult patients with squamous cell carcinoma of the tongue strongly express p16 without human papillomavirus infection.
Tachibana T; Orita Y; Gion Y; Miki K; Ikegami K; Marunaka H; Makino T; Akagi Y; Akisada N; Tsumura M; Ito T; Yoshino T; Nishizaki K; Sato Y
Acta Otolaryngol; 2019 Jan; 139(1):80-84. PubMed ID: 30712427
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
[TBL] [Abstract][Full Text] [Related]
8. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
9. TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence.
Haeggblom L; Näsman A; Ramqvist T; Haglund C; Hagström J; Mäkitie A; Dalianis T
Acta Otolaryngol; 2019 Feb; 139(2):206-210. PubMed ID: 30794027
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
12. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of Microrna-126 Contributes to Tumorigenesis of Squamous Tongue Cell Carcinoma via Targeting KRAS.
Han J; Wang L; Wang X; Li K
Med Sci Monit; 2016 Feb; 22():522-9. PubMed ID: 26883054
[TBL] [Abstract][Full Text] [Related]
14. Significance of PD-L1 Expression in Tongue Cancer Development.
Yoshida S; Nagatsuka H; Nakano K; Kogashiwa Y; Ebihara Y; Yano M; Yasuda M
Int J Med Sci; 2018; 15(14):1723-1730. PubMed ID: 30588196
[No Abstract] [Full Text] [Related]
15. P16(INK⁴a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas.
Larque AB; Conde L; Hakim S; Alos L; Jares P; Vilaseca I; Cardesa A; Nadal A
Virchows Arch; 2015 Apr; 466(4):375-82. PubMed ID: 25652585
[TBL] [Abstract][Full Text] [Related]
16. Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors.
Bidinotto LT; Véo CA; Loaiza EA; De França AP; Lorenzi AT; Rosa LA; De Oliveira CM; Levi JE; Scapulatempo-Neto C; Longatto-Filho A; Reis RM
Mol Med Rep; 2016 Oct; 14(4):3791-7. PubMed ID: 27573925
[TBL] [Abstract][Full Text] [Related]
17. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
18. [Expression of p15 and p16 proteins in tongue squamous cell carcinoma and their significances].
Liu XQ; Zeng RS; Huang HZ; Liao GQ
Ai Zheng; 2003 Nov; 22(11):1214-8. PubMed ID: 14613656
[TBL] [Abstract][Full Text] [Related]
19. [Detection and Analysis of EGFR and KRAS Mutations
in the Patients with Lung Squamous Cell Carcinomas].
Zhang H; Yang X; Qin N; Li X; Yang H; Nong J; Lv J; Wu Y; Zhang Q; Zhang X; Wang J; Su D; Zhang S
Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):621-5. PubMed ID: 26483334
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ
Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
